HU
Humacyte, Inc.
HUMA · NASDAQ
$0.58 -0.82% (-$0.00)
1M -11.99%
Market Cap $99.1M
P/E Ratio -
Div. Yield -
ROE 938.20%
Bulios Fair Price
$0.51
12.5% downside
Trenutna cena
$0.58
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HUMA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
32 /100
Expensive P/B 3.17x
P/S 46.73x
EV/FFO N/A
Growth
49 /100
Stable Book val. growth 70.15%
Rev. growth 9.20%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 5,240.78%
Gross margin 666.81%
FCF margin 4,599.72%
Quality
0 /100
Poor ROA 70.05%
ROIC 89.17%
Asset turnover 0.02x
Debt
30 /100
High Int. coverage -8.39x
Debt/Equity 2.12x
Current ratio 6.21x
Stability
1 /100
Unstable Profitable years 0
Beta 2.45x
EPS volatility 477.33%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HUMA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Laura E. Niklason
Employees
184
Headquarters
Durham
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report